Does Dr. DWAN VARNER have financial conflicts of interest?

Dr. DWAN VARNER (MD) has received a total of $55,390 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $55,390 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DWAN VARNER?

According to CMS Open Payments data, Dr. DWAN VARNER received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($55,129), JANSSEN PHARMACEUTICALS ($178), and NOVARTIS PHARMACEUTICALS CORPORATION ($24).

Does Dr. DWAN VARNER receive research grants or speaking fees?

Dr. DWAN VARNER has received $55,390 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DWAN VARNER

MDReal-Time Hydrated

Specialty: Hospitalist

Practice Location: GREENVILLE, NC 27834

NPI Number: 1538352711

LIFETIME INDUSTRY VALUE

$55,390

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. VARNER is a verified Hospitalist practitioner based in GREENVILLE, NC.

Between 2021 and 2025, Dr. VARNER had an overall industry promotional and research financial footprint of $55,390 as recorded in the federal CMS Open Payments database.

$55,390 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. VARNER's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $55,129 (representing 99.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$55,129

99.5%

JANSSEN PHARMACEUTICALS

Rank 2

$178

0.3%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$24

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.